![Christopher Paige](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christopher Paige
Direktor/Vorstandsmitglied bei Centre For Commercialization of Regenerative Medicine
Vermögen: 373 718 $ am 31.05.2024
Profil
Dr. Christopher Paige is a Professor at University of Toronto.
He is on the Board of Directors at Centre For Commercialization of Regenerative Medicine.
Dr. Paige was previously employed as an Independent Director by Avrobio, Inc., a Vice President-Research by University Health Network, a Director-Research by Wellesley Hospital, and a Member by Basel Institute for Immunology.
He also served on the board at Arthritis Research Foundation and Ontario Institute for Cancer Research.
He received his undergraduate degree from the University of Notre Dame and a doctorate degree from Cornell University Graduate School.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
0,56% | 07.03.2024 | 252 512 ( 0,56% ) | 373 718 $ | 31.05.2024 |
Aktive Positionen von Christopher Paige
Unternehmen | Position | Beginn |
---|---|---|
Centre For Commercialization of Regenerative Medicine
![]() Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | Direktor/Vorstandsmitglied | - |
University of Toronto | Corporate Officer/Principal | 01.01.1987 |
Ehemalige bekannte Positionen von Christopher Paige
Unternehmen | Position | Ende |
---|---|---|
TECTONIC THERAPEUTIC, INC. | Direktor/Vorstandsmitglied | 20.05.2024 |
University Health Network
![]() University Health Network Hospital/Nursing ManagementHealth Services University Health Network operates as a healthcare and medical research organization that provides patient care, education, and research services. Its programs include arthritis program, joint department of medical imaging, Krembil neuroscience center, laboratory medicine program, medical and community care, multi-organ transplant, Peter Munk cardiac center, Princess Margaret cancer, surgery and critical care program, and Toronto rehab. The company was founded in 1986 and is headquartered in Toronto, Canada. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2016 |
Basel Institute for Immunology | Corporate Officer/Principal | 01.01.1987 |
Arthritis Research Foundation | Direktor/Vorstandsmitglied | - |
Wellesley Hospital | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Christopher Paige
University of Notre Dame | Undergraduate Degree |
Cornell University Graduate School | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 6 |
---|---|
Ontario Institute for Cancer Research
![]() Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada. | Health Services |
Avrobio, Inc.
![]() Avrobio, Inc. BiotechnologyHealth Technology AVROBIO, Inc. engages in the development of lentiviral-based gene therapies. It focuses on developing potentially curative ex vivo lentiviral-based gene therapies to treat patients with rare diseases following a single dose treatment regimen. The firm's clinical-stage programs include Fabry, Gaucher Type 1, Hunter syndrome Gaucher Type 3, Pompe, and Cystinosis. The company was founded by Geoff Mackay, Kim Warren, Christopher Mason, and Jeffrey Medin in 2015 and is headquartered in Watertown, MA. | Health Technology |
Centre For Commercialization of Regenerative Medicine
![]() Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | Health Technology |
University Health Network
![]() University Health Network Hospital/Nursing ManagementHealth Services University Health Network operates as a healthcare and medical research organization that provides patient care, education, and research services. Its programs include arthritis program, joint department of medical imaging, Krembil neuroscience center, laboratory medicine program, medical and community care, multi-organ transplant, Peter Munk cardiac center, Princess Margaret cancer, surgery and critical care program, and Toronto rehab. The company was founded in 1986 and is headquartered in Toronto, Canada. | Health Services |
Wellesley Hospital | |
Arthritis Research Foundation |